Oramed Appoints Dr. Ronald Law as Chief Strategy Officer

JERUSALEM, March 21, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today the appointment of Dr. Ronald Law to the newly created position of Chief Strategy Officer. “We are very pleased to welcome Dr. Law to Oramed as we head towards a Phase III trial for our […]